New drug duos battle advanced ovarian cancer before surgery
NCT ID NCT07355010
Summary
This study is testing two different drug combinations to shrink tumors in people with advanced ovarian cancer before they have surgery. It's for patients whose cancer can't be fully removed with initial surgery or who can't tolerate that surgery. Researchers will compare how well the tumor responds to each combination and monitor side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.